Niu, Xiaoshuang
Liu, Peiyao
Wang, Xiaoshen
Hu, Chaosu
Article History
Received: 7 June 2023
Accepted: 29 September 2023
First Online: 12 October 2023
Declarations
:
: All patients provided informed written consent before treatment. This study was approved by the Institutional Review Boards of Fudan University Shanghai Cancer Center, China. All methods were carried out in accordance with relevant guidelines and regulation under the ‘Ethics approval and consent to participate’.
: Not applicable.
: No conflicts of interest to disclose.